Patient Compliance with Drug Therapy in Schizophrenia: Economic and Clinical Issues

Author： Lindström E.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.18, Iss.2, 2000-08, pp. : 105-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Therapy in Schizophrenia

By  

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2205-2217

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Drug Resistance Genotyping: A Review of Clinical and Economic Issues

By Chaix-Couturier C.  

PharmacoEconomics, Vol. 18, Iss. 5, 2000-11 ,pp. : 425-433

Adis International

Access to resources Recommend Favorite

A Pharmacokinetic Formalism Explicitly Integrating the Patient Drug Compliance

By Li Jun   Nekka Fahima  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 1, 2007-02 ,pp. : 115-139

Springer Publishing Company

Access to resources Recommend Favorite

Understanding Patient Compliance and Persistence with Osteoporosis Therapy

By Gold Deborah T.  

Drugs & Aging, Vol. 28, Iss. 4, 2011-04 ,pp. : 249-255

Adis International

Access to resources Recommend Favorite

Economic Aspects on Drug Therapy of Dementia

By  

Current Pharmaceutical Design, Vol. 10, Iss. 3, 2004-01 ,pp. : 295-301

Bentham Science Publishers

Access to resources Recommend Favorite